APA (7th ed.) Citation

PH, W., JP, D., X, Y., U, V., CI, F., JM, R., & PA, C. (2010). Phase II study of interleukin-4 in indolent B-cell non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia: A study of the Eastern Cooperative Oncology Group (E5Y92). Journal of immunotherapy (Hagerstown, Md. : 1997), 33(9), 1006. https://doi.org/10.1097/CJI.0b013e3181f5dfc5

Chicago Style (17th ed.) Citation

PH, Wiernik, Dutcher JP, Yao X, Venkatraj U, Falkson CI, Rowe JM, and Cassileth PA. "Phase II Study of Interleukin-4 in Indolent B-cell Non-Hodgkin Lymphoma and B-cell Chronic Lymphocytic Leukemia: A Study of the Eastern Cooperative Oncology Group (E5Y92)." Journal of Immunotherapy (Hagerstown, Md. : 1997) 33, no. 9 (2010): 1006. https://doi.org/10.1097/CJI.0b013e3181f5dfc5.

MLA (9th ed.) Citation

PH, Wiernik, et al. "Phase II Study of Interleukin-4 in Indolent B-cell Non-Hodgkin Lymphoma and B-cell Chronic Lymphocytic Leukemia: A Study of the Eastern Cooperative Oncology Group (E5Y92)." Journal of Immunotherapy (Hagerstown, Md. : 1997), vol. 33, no. 9, 2010, p. 1006, https://doi.org/10.1097/CJI.0b013e3181f5dfc5.